| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.0071 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |